000			02110 a2200601 4500
005			20250516201957.0
264		0	_c20150102
008			201501s 0 0 eng d
022			_a1445-5994
024	7		_a10.1111/imj.12397 _2doi
040			_aNLM _beng _cNLM
100	1		_aSubramaniam, K
245	0	0	_aEarly predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy. _h[electronic resource]
260			_bInternal medicine journal _cMay 2014
300			_a464-70 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdalimumab
650	0	4	_aAdrenal Cortex Hormones _xpharmacology
650	0	4	_aAdult
650	0	4	_aAnti-Inflammatory Agents _xadverse effects
650	0	4	_aAntibodies, Monoclonal _xadministration & dosage
650	0	4	_aAntibodies, Monoclonal, Humanized _xadministration & dosage
650	0	4	_aColectomy _xstatistics & numerical data
650	0	4	_aColitis, Ulcerative _xdrug therapy
650	0	4	_aDisease-Free Survival
650	0	4	_aDrug Resistance
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xadministration & dosage
650	0	4	_aInfliximab
650	0	4	_aMale
650	0	4	_aMesalamine _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aObservational Studies as Topic
650	0	4	_aPrognosis
650	0	4	_aProportional Hazards Models
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aRecurrence
650	0	4	_aRemission Induction
650	0	4	_aRisk Factors
650	0	4	_aSeverity of Illness Index
650	0	4	_aTreatment Outcome
650	0	4	_aTumor Necrosis Factor-alpha _xantagonists & inhibitors
700	1		_aRichardson, A
700	1		_aDodd, J
700	1		_aPlatten, J
700	1		_aShadbolt, B
700	1		_aPavli, P
773	0		_tInternal medicine journal _gvol. 44 _gno. 5 _gp. 464-70
856	4	0	_uhttps://doi.org/10.1111/imj.12397 _zAvailable from publisher's website
999			_c23624276 _d23624276